Global Artificial Pancreas Device System Market Size By Device Type (Threshold Suspended System, Control-To-Range (CTR) System, And Control-To-Target (CTT) System), By End User (Hospitals And Clinics And Homecare Settings), By Geographic Scope And Forecast

Artificial Pancreas Device System Market Size And Forecast

Artificial Pancreas Device System Market size was valued at USD 1253.3 Billion in 2024 and is projected to reach USD 5108.17 Billion by 2031, growing at a CAGR of 19.20% from 2024 to 2031.

• The Artificial Pancreas Device System (APDS) is an innovative medical technology designed to manage blood sugar levels in individuals with diabetes.
• The APDS is a closed-loop system that integrates continuous glucose monitoring (CGM) with an insulin pump and a control algorithm.
• It mimics the function of the pancreas by automatically adjusting insulin delivery based on real-time glucose levels.
• Continuous Glucose Monitoring (CGM) sensors are implanted or worn externally to measure glucose levels in the interstitial fluid continuously.
• These sensors transmit glucose data to the control algorithm, providing real-time feedback on blood sugar levels.
• An insulin pump is connected to the APDS to deliver insulin subcutaneously. The pump can administer both basal insulin to maintain steady glucose levels throughout the day and bolus insulin to address mealtime glucose spikes.
• The control algorithm serves as the brain of the APDS, processing glucose data from the CGM and determining the appropriate insulin dose.
• It adjusts insulin delivery based on glucose trends, aiming to keep blood sugar levels within a target range.
• The APDS automatically adjusts insulin delivery in response to glucose fluctuations, reducing the need for manual intervention by the user.
• This automation enhances glucose control and minimizes the risk of hypo- and hyperglycemia.
• The closed-loop operation of the APDS means that glucose data is continuously fed into the control algorithm, which then calculates and administers insulin doses in real time.
• This closed-loop system provides precise glucose management without user intervention.

To Get Detailed Analysis: Download Report PDF

Global Artificial Pancreas Device System Market Dynamics

The key market dynamics that are shaping the global artificial pancreas device system market include:

Key Drivers

• Rising Prevalence of Diabetes: The FDA has reported a 39.2% increase in the use of continuous glucose monitoring devices among people with Type 1 diabetes between 2017 and 2021. The increasing global incidence of diabetes, particularly type 1 diabetes, has created a demand for effective management solutions, driving the adoption of artificial pancreas systems.
• Technological Advancements: Innovations in continuous glucose monitoring (CGM) and insulin delivery technologies have enhanced the efficacy and usability of artificial pancreas devices, promoting their market growth.
• Increasing Awareness and Acceptance: Growing awareness of diabetes management options and increased acceptance of technology-based solutions among patients and healthcare providers have boosted demand for artificial pancreas systems.
• Government Initiatives and Support: Policies and funding from governments and health organizations to support diabetes management technologies contribute to the growth of the artificial pancreas device market.
• Improved Quality of Life: The potential of artificial pancreas systems to provide better glycemic control and reduce the burden of diabetes management on patients enhances their attractiveness.

Key Challenges

• High Cost of Devices: The high price of artificial pancreas systems can be a barrier to adoption for many patients, limiting market growth.
• Technical Limitations: Challenges related to the accuracy of glucose monitoring and insulin delivery can impact the reliability and effectiveness of artificial pancreas systems.
• Regulatory Hurdles: Obtaining regulatory approval for new devices can be a lengthy and complex process, posing challenges for manufacturers in the market.
• User Acceptance and Compliance: Ensuring patient acceptance and adherence to using artificial pancreas devices remains a challenge, as some patients may prefer traditional management methods.
• Data Security and Privacy Concerns: With the integration of digital technologies, concerns about data security and privacy can hinder the adoption of connected artificial pancreas systems.

Key Trends

• Integration of Digital Health Technologies: The incorporation of mobile applications and telehealth services for monitoring and managing diabetes is a growing trend in the artificial pancreas market.
• Miniaturization of Devices: Advances in miniaturization technology are leading to the development of smaller, more user-friendly artificial pancreas systems that are easier for patients to use.
• Wearable Technology: The rise of wearable devices that monitor glucose levels and deliver insulin is becoming a prominent trend, providing convenience and continuous monitoring for users.
• Personalized Medicine: A shift towards personalized treatment plans, with artificial pancreas systems tailored to individual patient needs, is gaining traction in diabetes management.
• Regulatory Approvals and Collaborations: Increasing collaborations between technology companies and healthcare providers, along with regulatory approvals for new devices, are shaping market dynamics.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=31343

Global Artificial Pancreas Device System Market Regional Analysis

Here is a more detailed regional analysis of the global artificial pancreas device system market:

North America

• North America significantly dominates in the Global Artificial Pancreas Device System Market, driven by robust demand from various sectors, including defense, healthcare, industrial, and commercial applications.
• According to the Centers for Disease Control and Prevention (CDC), 37.3 million Americans (about 11.3% of the population) have diabetes, with approximately 1.4 million new cases diagnosed each year. Of these, the CDC reports that about 1.9 million people have Type 1 diabetes, the primary target group for artificial pancreas systems.
• The region’s strong defense budget, particularly in the United States, supports substantial investments in advanced surveillance technologies, making it a key driver for thermal imaging adoption.
• Law enforcement agencies also increasingly utilize thermal imaging for border security and crime prevention, enhancing public safety.
• In the healthcare sector, thermal imaging has gained prominence, especially for non-invasive diagnostic applications, such as detecting fevers and monitoring patients in hospitals.
• The COVID-19 pandemic accelerated this trend, as organizations sought effective methods for temperature screening in public spaces.
• Furthermore, the industrial sector leverages thermal imaging for predictive maintenance and energy efficiency, helping companies reduce downtime and operational costs.
• The presence of leading thermal imaging manufacturers and technological innovators, such as FLIR Systems and Teledyne Technologies, further bolsters the market’s growth.
• With ongoing advancements in technology and increasing applications across various industries, the North American thermal imaging market is poised for continued expansion, driven by a combination of security needs, technological innovation, and a focus on operational efficiency.

Asia Pacific

• The Asia Pacific region is anticipated to experience the fastest growth in the Global Artificial Pancreas Device System Market fueled by rising demand across various sectors, including defense, healthcare, and industrial applications.
• Countries like China, India, and Japan are at the forefront of this expansion, driven by increasing government investments in defense and security initiatives.
• The need for advanced surveillance technologies in military applications has led to heightened adoption of thermal imaging systems.
• In the healthcare sector, the COVID-19 pandemic has accelerated the use of thermal imaging for non-contact temperature monitoring in hospitals, airports, and public spaces.
• This technology has become essential for detecting potential health risks in crowded environments.
• The industrial sector is also contributing to market growth, with companies increasingly utilizing thermal imaging for predictive maintenance, energy audits, and equipment monitoring.
• This trend is particularly notable in manufacturing, construction, and energy industries, where efficiency and safety are paramount.
• Technological advancements in thermal imaging, such as the development of smaller, more portable devices and integration with IoT solutions, are enhancing its applicability across various fields.
• As awareness of thermal imaging benefits continues to grow, the Asia Pacific region is expected to emerge as a key player in the global thermal imaging market.

Global Artificial Pancreas Device System Market: Segmentation Analysis

The Global Artificial Pancreas Device System Market is segmented based on Device Type, End User, And Geography.

Artificial Pancreas Device System Market, By Device Type

• Threshold Suspended System
• Control-to-Range (CTR) System
• Control-to-Target (CTT) System

Based on Device Type, the Global Artificial Pancreas Device System Market is bifurcated into Threshold Suspended System, Control-to-Range (CTR) System, and Control-to-Target (CTT) System. The Control-to-Target (CTT) System is the dominant market. This technology excels at giving precise insulin doses to keep blood glucose levels within a defined target range, which improves diabetes control. CTT systems dynamically alter insulin delivery based on real-time glucose readings, ensuring tight glycemic control and reducing the risk of hypoglycemia and hyperglycemia.

Artificial Pancreas Device System Market, By End User

• Hospitals and Clinics
• Homecare Settings

Based on End Users, the Global Artificial Pancreas Device System Market is bifurcated into Hospitals clinics, and home care settings. The dominant segment is Homecare Settings. With technological developments and more patient empowerment, there is a growing trend of managing chronic illnesses, such as diabetes, from home. Homecare environments give diabetics more control and flexibility in treating their disease, which aligns with the trend toward patient-centered care. Artificial pancreas devices for home usage offer continuous glucose monitoring and automated insulin delivery, allowing for easy incorporation into daily activities.

Artificial Pancreas Device System Market, By Geography

• North America
• Europe
• Asia-Pacific
• Rest of the world

Based on Geography, the Global Artificial Pancreas Device System Market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World. North America significantly dominates in the Global Artificial Pancreas Device System Market, driven by robust demand from various sectors, including defense, healthcare, industrial, and commercial applications. According to the Centers for Disease Control and Prevention (CDC), 37.3 million Americans (about 11.3% of the population) have diabetes, with approximately 1.4 million new cases diagnosed each year. Of these, the CDC reports that about 1.9 million people have Type 1 diabetes, the primary target group for artificial pancreas systems.  The region’s strong defense budget, particularly in the United States, supports substantial investments in advanced surveillance technologies, making it a key driver for thermal imaging adoption.

Key Players

The “Global Artificial Pancreas Device System Market” study report provides valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Tandem Diabetes Care, Insulet Corporation, Johnson & Johnson, Bigfoot Biomedical, Beta Bionics, Abbott Laboratories, Roche Diabetes Care, Diacare, and Medtronic MiniMed.

This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Artificial Pancreas Device System Market Key Developments

• In May 2024, Medtronic announced the launch of its latest artificial pancreas system, which featured advanced sensor technology and personalized insulin delivery algorithms for improved glucose management.
• In April 2024, Tandem Diabetes Care announced the launch of its next-generation insulin pump system with enhanced connectivity and integration capabilities, offering users greater flexibility and control over their diabetes management.
• In June 2024, Insulet Corporation announced a new version of its tubeless insulin pump system, which incorporated user feedback and advanced features for enhanced comfort and convenience in diabetes management.
• In March 2024, Johnson & Johnson announced the development of a novel closed-loop insulin delivery system that leveraged artificial intelligence and predictive analytics to optimize glucose control in individuals with diabetes.

Report Scope

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.